γδ T cells for cancer immunotherapy: A systematic review of clinical trials - Test2 - elhamkhani - TriplyDB

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

http://www.wikidata.org/entity/Q27021705

about

Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy Regeneration of stalled immune responses to transformed and infected cells using γδ T cells Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation Immunotherapy in human colorectal cancer: Challenges and prospective Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells.Clinical applications of gamma delta T cells with multivalent immunity.Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis 2015 Guidance on cancer immunotherapy development in early-phase clinical studies.Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells.Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor.Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells γδ T Cell-Mediated Immunity to Cytomegalovirus Infection.Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma.γδ T Cell-Mediated Immune Responses in Disease and Therapy γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy.Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors.Gammadelta T Cells in Crohn's Disease: A New Player in the Disease Pathogenesis?Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients.Apoptosis Induced via Gamma Delta T Cell Antigen Receptor "Blocking" Antibodies: A Cautionary Tale Editorial: "Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives".TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance.Immunosuppressive γδ T cells foster pancreatic carcinogenesis.Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells.Integration of oncogenes via Sleeping Beauty as a mouse model of HPV16+ Oral tumor and immunologic control.Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT).

P2860

Q26750995-B7D8231C-9B14-4CA9-84FE-3379274FD299 Q26781175-D213CBE4-48A7-4CD7-A028-2708D33561E8 Q26823185-73C5C398-A754-486A-B83F-62F3AC18A2D1 Q26863724-8705B665-CA77-482B-9BA2-977854515B13 Q28068788-B9B9A564-DA87-4C40-AF08-DE2818756306 Q28085397-4C0FA2A3-6508-4C5C-93F9-3DDD810F944B Q33855566-C93F770E-5D6D-4671-9922-4950D39E0EBF Q34502154-E44718CD-D419-4DB7-A39B-920E971D9AA7 Q34677859-CA69331E-D6A3-4E40-A6AA-258598B872FB Q35677421-5084CA83-08E3-4D4F-9BE9-4E37552B6DEA Q35799192-4AAA9499-38B8-4213-A850-D71F13B44176 Q35803534-D0920DEF-6ED4-43B4-B901-A1637A2B4339 Q35935862-3279D225-12C2-4314-BE39-7BB624B260C6 Q35937473-550A1A71-3F6D-4BB3-AB3D-9A9AA2E05BA0 Q36467378-9ED9A369-9E8B-4C93-A8B3-08A1A45872C2 Q36597374-13D2EDF0-0971-4FCB-A417-DDDFE238F2AD Q36734208-7D0A4ECC-3245-4060-B1B0-BD0331760FE6 Q37279963-7F0EE523-37AD-4416-A3A1-D8392AC9EBB2 Q37294760-7A487353-5CFE-45D8-9B8F-BC4E5AA279C6 Q37632938-624238BD-3818-4F2E-B90C-C4A0EC8E0A34 Q37655345-C4FC1C6D-9ED3-4A24-ACFA-D1CA681C06A3 Q37701514-723EC3EE-57C3-451B-97F8-163D8DF47D61 Q38271584-EE096980-73BD-4368-A83A-3375E08D7CE1 Q38271585-52D04172-3FA7-4A18-9C57-59C369FA60F4 Q38283536-B9727DE1-3A4A-4B0E-A38B-10815681FF28 Q38730126-F06B465B-EAA9-41E9-8CD1-B510C0E962A6 Q38839878-9A3A141A-CEB5-45ED-9886-6563E6F6C101 Q39195619-FA4B2A18-CED3-49E1-86F9-52513E70BE0A Q39832849-54B323CD-5086-4776-B81F-E02DA0738918 Q40267794-F6745CF9-7054-4E10-90C7-8764CE62457C Q40808689-096FC010-F879-425F-9D13-590D67DEEE85 Q40989863-8A01C672-3C9B-440A-B87A-B415AA9DC834 Q41061926-CE4625BD-0113-4578-B6DD-C2D3C9153644 Q41118007-81E21971-4364-47E9-96AF-6EE7631C8C04 Q42357971-C391B5E3-D33E-4507-84C7-5085751F6F34 Q47146669-CB0BBDF3-6EBA-49EF-843D-2F0C69D91698 Q47549568-E9D15F3B-37A7-41AC-98D1-4C5C1FBE198C Q48128395-EB8D3B46-89AE-4E61-80F2-589437C612D2 Q48359042-6E08844D-0B75-4DBE-AF3E-6837216ADB70 Q49333274-A5A9D25C-2CC9-4625-A0DC-560CEB82CB64

P2860

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

http://www.wikidata.org/entity/Q27021705

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@ast

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@en

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@nl

type

label

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@ast

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@en

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@nl

prefLabel

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@ast

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@en

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@nl

P1433

Q27021705-11E02143-CD7D-4B55-9EE3-49FAF30A0635

P1476

Q27021705-9ECEF5F2-13C7-4DA9-9430-341F6287194C

P2093

Q27021705-3BD9670C-99A9-48BE-8610-3545DECC48F0

Q27021705-487067A5-F705-4FDB-A06E-DC3B082ADA78

Q27021705-9862E8CB-B5DA-4138-AD94-751AD8EDC089

Q27021705-AB2952F6-D766-45ED-B113-8301F25C6D9F

P2860

Q27021705-0035F4AF-0DDB-41A3-AB19-56BA8365EF1A

Q27021705-0540143A-C33A-48B9-8F68-8B612122C408

Q27021705-09B0B4ED-E8A2-41BF-9D83-561D9F5AD89B

Q27021705-0B0F16A1-8212-45DB-82AF-F146ADA5A7BF

Q27021705-0C59436F-72BF-4A39-BD9E-88D100D5EF54

Q27021705-0DF76B0C-34EE-4AB9-A195-556C2A9EB28D

Q27021705-112B9FDC-9B6C-4EBF-8275-DA2DA6CC533D

Q27021705-14381572-7B70-486D-A21C-C8D6584FA65B

Q27021705-19273404-7C3B-42B0-978F-8F5048C142F3

Q27021705-1B493D98-1B9C-442E-A155-13CCF1683DBF

P304

Q27021705-E40D70DF-AAA3-4EBF-8160-7E4201B2876D

P31

Q27021705-46ED9BEC-79AC-4334-855A-28E82E74D4BD

Q27021705-8FE7F2DD-B5C2-4544-9BFB-7F491C1A512B

P3181

Q27021705-2F89AB89-3A9A-494C-93BD-66558B325BAC

P356

Q27021705-7AA732C5-5D4A-498B-90B5-31B8BD671BC1

P433

Q27021705-DC76F491-F586-49DF-A8DE-C7497BEC67B5

P478

Q27021705-5FA20E29-15EA-4387-B111-C8CA3775D81B

P50

Q27021705-F452AFB5-1945-48A3-8C26-8FF0968AB5EF

P577

Q27021705-D48B4FB3-1F9D-4FF9-85F2-57F18F522663

P5875

Q27021705-FD20AA90-CA3E-46F9-A086-B4B3EAF10727

P698

Q27021705-ACF71665-BB2F-4C4F-AF33-2FD0E401D9A1

P921

Q27021705-D21B6897-ADDA-417A-94EE-042BFC57CA98

P932

Q27021705-B331B361-6F90-4D47-A738-EF82A1068B09

P3181

P356

P1433

P1476

γδ T cells for cancer immunotherapy: A systematic review of clinical trials

@en

P2093

Jennifer Heuijerjans

http://www.w3.org/2001/XMLSchema#string

John Anderson

http://www.w3.org/2001/XMLSchema#string

Kenth Gustafsson

http://www.w3.org/2001/XMLSchema#string

Mengyong Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Six-of-the-best: unique contributions of γδ T cells to immunology

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis

Antibacterial effect of human V gamma 2V delta 2 T cells in vivo

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Cancer immunotherapy via dendritic cells

P304

e27572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

3268579

http://www.w3.org/2001/XMLSchema#string

P356

10.4161/ONCI.27572

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan Fisher

P577

2014-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261738196

http://www.w3.org/2001/XMLSchema#string

P698

24734216

http://www.w3.org/2001/XMLSchema#string

P921

P932

3984269

http://www.w3.org/2001/XMLSchema#string